Tirzepatide interacts with two natural hormones, GIP and GLP-1, that play roles in blood sugar and appetite regulation.
By activating receptors in the pancreas and brain, it may enhance insulin release, influence glucagon activity, slow gastric emptying, and affect appetite signals, supporting reduced intake, satiety, and overall metabolic balance over time.
Tirzepatide is a physician-compounded injectable therapy that acts on both GIP and GLP-1 hormone pathways. It may influence appetite signals and aspects of metabolic health, with medical oversight guiding personalized use for weight management.






Reviews
There are no reviews yet.